In Escalation: All Patients With Solid Tumors and Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14892 | Spartalizumab | 1 | Terminated | 1 |
| DB14922 | Tislelizumab | 1 | Terminated | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14892 | Spartalizumab | 1 | Terminated | 1 |
| DB14922 | Tislelizumab | 1 | Terminated | 1 |